Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration

被引：3
|
作者：
Sazanami, Kohei [1 ,2 ]
Inose, Ryo [2 ]
Dote, Satoshi [1 ]
Horiuchi, Nozomu [1 ]
Kobayashi, Yuka [1 ]
Muraki, Yuichi [2 ]
机构：
[1] Kyoto Katsura Hosp, Dept Pharm, Kyoto, Japan
[2] Kyoto Pharmaceut Univ, Dept Clin Pharmacoepidemiol, Kyoto, Japan
来源：
JOURNAL OF CHEMOTHERAPY | 2021年 / 33卷 / 06期
关键词：
D O I：
10.1080/1120009X.2020.1848298
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients
    Buhlinger, Kaitlyn M.
    Fuller, Kathryn A.
    Faircloth, Cassidy B.
    Wallace, Jessica R.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (16) : 1204 - 1210
  • [42] Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy Infectious Diseases
    Kim T.
    Kandiah S.
    Patel M.
    Rab S.
    Wong J.
    Xue W.
    Easley K.
    Anderson A.M.
    BMC Research Notes, 8 (1)
  • [43] Nephrotoxic Risk Associated With Combination Therapy of Vancomycin and Piperacillin-Tazobactam in Critically Ill Patients With Chronic Kidney Disease
    Pipkin, Tamyah
    Pope, Stuart
    Killian, Alley
    Green, Sarah
    Albrecht, Benjamin
    Nugent, Katherine
    JOURNAL OF INTENSIVE CARE MEDICINE, 2024, 39 (09) : 860 - 865
  • [44] Risk and Time-to-Onset of Acute Kidney Injury With Vancomycin Plus Piperacillin-tazobactam Combination: Analysis Using JADER
    Ide, Naohito
    Sako, Ken-Ichi
    Takigawa, Masaki
    Tanaka, Hiroyuki
    IN VIVO, 2024, 38 (03): : 1436 - 1442
  • [45] Risk of Acute Kidney Injury and Clostridioides difficile Infection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin
    Lee, Jazmin D.
    Heintz, Brett H.
    Mosher, Hilary J.
    Livorsi, Daniel J.
    Egge, Jason A.
    Lund, Brian C.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E1579 - E1586
  • [46] Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients
    LeCleir, Lisa K.
    Pettit, Rebecca S.
    PEDIATRIC PULMONOLOGY, 2017, 52 (08) : 1000 - 1005
  • [47] PIPERACILLIN-TAZOBACTAM VERSUS CEFEPIME INCIDENCE OF ACUTE KIDNEY INJURY IN COMBINATION WITH VANCOMYCIN AND TOBRAMYCIN IN PEDIATRIC CYSTIC FIBROSIS PATIENTS
    LeCleir, L. K.
    Pettit, R. S.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 325 - 325
  • [48] Acute Kidney Injury in Pediatric Patients Treated with Vancomycin and Piperacillin-Tazobactam Versus Vancomycin and Cefotaxime: A Single-center Study
    Alqurashi, Rewaa
    Batwa, Mawaddah
    Alghamdi, Bashayer
    Aljohani, Saja
    Zaher, Nada
    Alzahrani, Amal
    Aldigs, Eman
    Safdar, Osama
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (01)
  • [49] Nut Cracked? Does the ACORN Trial End the Debate Surrounding Vancomycin and Piperacillin-Tazobactam Combination Therapy and Increased Risk for Acute Kidney Injury?
    Pogue, Jason M.
    Aitken, Samuel L.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (01):
  • [50] Acute Kidney Injury during Vancomycin Therapy Associated with Combination Use of Piperacillin-Tazobactam after Allogeneic Stem Cell Transplantation
    Kariya, Misato
    Shimomura, Yoshimitsu
    Hiramoto, Nobuhiro
    Okada, Yutaka
    Ootoshi, Ai
    Maki, Haruka
    Hashimoto, Hisako
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S281 - S282
12345